GOSHO Masahiko

Researcher's full information

Articles
  • Morningness eveningness questionnaire score and metabolic parameters in patients with type 2 diabetes mellitus
    Osonoi Y; Mita T; Osonoi T; Saito M; Tamasawa A; Nakayama S; So...
    Chronobiology International/31/pp.1017-1023, 2014-11
  • Effect of covariate omission in Weibull accelerated failure time model: A caution
    Gosho M; Maruo K; Sato Y
    Biometrical Journal/56/pp.991-1000, 2014-11
  • Effects of eicosapentaenoic acid on peri-procedural (Type IVa) myocardial infarction following elective coronary stenting
    Kurita A; Takashima H; Ando H; Kumagai S; Waseda K; Gosho M; Am...
    Journal of Cardiology, 2014-10
  • Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma
    Tsurusawa M; Gosho M; Mori T; Kikuchi A; Mitsui T; Sunami S; Ko...
    Pediatric Blood & Cancer/62/pp.279-284, 2014-10
  • Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma
    Nishimura K; Tsuchiya Y; Okamoto H; Ijichi K; Gosho M; Fukayam...
    British Journal of Cancer/111/pp.799-806, 2014-08
  • Impact of chronic obstructive pulmonary disease on composition of left main coronary artery plaque with intermediate stenosis
    Kumagai S; Ishii H; Takashima H; Waseda K; Kuroda Y; Kosaka T; ...
    International Journal of Cardiology/174/pp.865-866, 2014-07
  • Correlation between optic nerve head structural parameters and glaucomatous visual field indices
    Mizumoto K; Gosho M; Zako M
    Clinical Ophthalmology/8/pp.1203-1208, 2014-06
  • Enhanced expression of WD repeat-containing protein 35 via CaMKK/AMPK activation in bupivacaine-treated Neuro2a cells
    Huang L; Kondo F; Gosho M; Feng G-G; Harato M; Ishikawa N; Fuji...
    PLOS ONE/9/p.e98185, 2014-05
  • Cumulative effect of lesion morphology and location on the functional significance in patient with intermediate stenotic coronary lesions
    Takashima H; Waseda K; Kurita A; Ando H; Gosho M; Sakurai S; Ku...
    Circulation/130/p.A11687, 2014
  • Prevalence of Helicobacter pylori infection by birth year and geographic areas in Japan
    Ueda J; Gosho M; Inui Y; Matsuda T; Sakakibara M; Mabe K; Nakaj...
    Helicobacter/19/pp.105-110, 2014-04
  • Rationale, design, and baseline characteristics of a trial for prevention of atherosclerosis in patients with insulin treated diabetes mellitus using a DPP-4 inhibitor: Sitagliptin Preventive study of Intima media thickness Evaluation (SPIKE)
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi...
    Diabetology & Metabolic Syndrome/6/pp.1-10, 2014-03
  • Criteria to select a working correlation structure for generalized estimating equations method in SAS
    Gosho M
    Journal of Statistical Software/57/pp.1-10, 2014-03
  • Reliability and validity of the Japanese version of the diabetes quality-of-life questionnaire for Japanese patients with type 2 diabetes mellitus
    Sato F; Mita M; Yamamoto R; Hirose T; Ito C; Tamura Y; Yokota A...
    Diabetology International/5/pp.21-29, 2014-03
  • Robust covariance estimator for small-sample adjustment in the generalized estimating equations: A simulation study
    Gosho M; Sato Y; Takeuchi H
    Science Journal of Applied Mathematics and Statistics/2/pp.20-25, 2014-02
  • Carotid intima-media thickness progression predicts cardiovascular events in patients with type 2 diabetes
    Okayama IK; Mita T; Gosho M; Yamamoto R; Yoshida M; Kanazawa A...
    Diabetes Research and Clinical Practice/101/pp.286-292, 2013-10
  • Selection of working correlation structure in weighted generalized estimating equation method for incomplete longitudinal data
    Gosho M; Hamada C; Yoshimura I
    Communications in Statistics – Simulation and Computation/43/pp.62-81, 2013-08
  • Rationale, design, and baseline characteristics of a trial for prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
    Katakami N; Mita T; Yoshii H; Onuma T; Kaneto H; Osonoi T; Shir...
    Journal of Atherosclerosis and Thrombosis/20/pp.893-902, 2013-08
  • Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
    Mita T; Nakayama S; Abe H; Gosho M; Iida H; Hirose T; Kawamori ...
    Journal of Diabetes Investigation/4/pp.297-303, 2013-05
  • Pitavastatin concentrations are not increased by CYP3A4 inhibitor itraconazole in healthy subjects
    Nakagawa S; Gosho M; Inazu Y; Hounslow N
    Clinical Pharmacology in Drug Development/2/pp.195-200, 2013-04
  • Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia
    Stender S; Budinski D; Gosho M; Hounslow N
    European Journal of Preventive Cardiology/20/pp.40-53, 2013-02
  • Comparison of algorithms for generating Poisson random vectors: a review
    Gosho M; Maruo K
    InterStat/1/pp.1-10, 2012-08
  • Study designs and statistical analyses for biomarker research
    Gosho M; Nagashima K; Sato Y
    Sensors/12/pp.8966-8986, 2012-06
  • バイオマーカー探索的研究デザイン
    五所正彦; 長島健悟; 佐藤泰憲
    日本臨牀/70/pp.874-879, 2012-05
  • Usefulness of statistics for establishing evidence-based reproductive medicine
    Sato Y; Gosho M; Toshimori K
    Reproductive Medicine and Biology/11/pp.49-58, 2012-01
  • Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes, Obesity and Metabolism/13/pp.1047-1055, 2011-11
  • more...